| 000 | 01829 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250512104112.0 | ||
| 264 | 0 | _c19700319 | |
| 008 | 197003s 0 0 eng d | ||
| 022 | _a0028-4793 | ||
| 024 | 7 |
_a10.1056/NEJM197003052821001 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGilmore, E | |
| 245 | 0 | 0 |
_aTreatment of essential hypertension with a new vasodilator in combination with beta-adrenergic blockade. _h[electronic resource] |
| 260 |
_bThe New England journal of medicine _cMar 1970 |
||
| 300 |
_a521-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdrenergic alpha-Antagonists _xtherapeutic use |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAldosterone _xurine |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aCardiac Output _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aForearm _xblood supply |
| 650 | 0 | 4 | _aGlomerular Filtration Rate |
| 650 | 0 | 4 |
_aHeart _xdrug effects |
| 650 | 0 | 4 |
_aHeart Rate _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension _xdrug therapy |
| 650 | 0 | 4 |
_aKidney _xblood supply |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNorepinephrine _xurine |
| 650 | 0 | 4 |
_aPiperidines _xtherapeutic use |
| 650 | 0 | 4 | _aPosture |
| 650 | 0 | 4 |
_aPropranolol _xpharmacology |
| 650 | 0 | 4 |
_aPyrimidines _xtherapeutic use |
| 650 | 0 | 4 |
_aSodium _xmetabolism |
| 650 | 0 | 4 | _aValsalva Maneuver |
| 650 | 0 | 4 |
_aVanilmandelic Acid _xurine |
| 650 | 0 | 4 |
_aVascular Resistance _xdrug effects |
| 650 | 0 | 4 |
_aVasodilator Agents _xtherapeutic use |
| 700 | 1 | _aWeil, J | |
| 700 | 1 | _aChidsey, C | |
| 773 | 0 |
_tThe New England journal of medicine _gvol. 282 _gno. 10 _gp. 521-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1056/NEJM197003052821001 _zAvailable from publisher's website |
| 999 |
_c4396412 _d4396412 |
||